Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

43.74
Delayed Data
As of 4:02pm ET
 -0.16 / -0.36%
Today’s Change
36.71
Today|||52-Week Range
45.58
+9.95%
Year-to-Date
Top Research Reports for August 25, 2016
2:51pm / Zacks.com - Paid Partner Content
Inovio Expands Enrollment in Ebola Vaccine Phase I Study
Aug 15 / Zacks.com - Paid Partner Content
Henderson Revises Global Dividend Expectations Lower For 2016
Aug 22 / TheStreet.com - Paid Partner Content
Bristol-Myers' Revolutionary Cancer Drug Suffers A Big Blow
Aug 14 / MotleyFool.com - Paid Partner Content
3 High-Yielding Healthcare Stocks I'm Not Buying
Aug 20 / MotleyFool.com - Paid Partner Content
Struggling in China, foreign firms seek to become more Chinese
Aug 02 / CNNMoney.com
Teva Cinqaero Gets EU Nod for Severe Eosinophilic Asthma
Aug 19 / Zacks.com - Paid Partner Content
Google partners with GlaxoSmithKline on $700 million 'bioelectronic' venture
Aug 01 / CNNMoney.com
Glaxo/Pfizer ViiV Healthcare Starts HIV Drug Combo Study
Aug 17 / Zacks.com - Paid Partner Content